Clinical Trial

Intestinal Microbiota Transplantation for Treating Advanced Tumor Cachexia

Study acronym: FMT-CACH
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This project is a prospective, multicenter, single-arm, phase II clinical study aimed at evaluating the efficacy and safety of fecal microbiota transplantation (FMT) in treating advanced tumor cachexia.
Trial Details
NCT Number NCT07533227
Lead Sponsor Hua Jiang
Conditions Cachexia; Cancer, Fecal Microbiota Transplantation (FMT)
Enrollment 66 participants
Start Date 2026-05-01
Primary Completion 2027-05-01 (estimated)
Study Completion 2027-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-16